March 2, 2022
Life Sciences
  • The National Institutes of Health ordered a major review of federal biosecurity policies for experiments involving potentially dangerous pathogens. The agency hopes to gather recommendations by the end of 2022 on where to draw the line on potentially risky research. The review is unrelated to debate over the origins of the COVID-19 pandemic. (Article here)